首页> 外文学位 >Preparation of nonthrombogenic polymer surfaces: Immobilization of heparin and dextran oligosaccharides.
【24h】

Preparation of nonthrombogenic polymer surfaces: Immobilization of heparin and dextran oligosaccharides.

机译:制备非血栓性聚合物表面:固定肝素和葡聚糖寡糖。

获取原文
获取原文并翻译 | 示例

摘要

Blood compatibility is a major concern in the development of synthetic biomaterials since most synthetic polymers will induce thrombosis formation on their surfaces once contact with blood or tissue. The objective of this thesis is to develop surface modification procedures for existing biomaterials, that will specifically inhibit the surface induced thrombosis and extend the lifetime of blood-contacting biomedical implants and devices. Three approaches have been developed to prepare the nonthrombogenic interfaces for biomaterials and devices.;The first approach involved the surface modification of biomaterials by radiofrequency plasma discharge. Two plasma polymer thin films (approx. 110 nm) were deposited on PE. Plasma polymer modified polyethylene surfaces exhibited significant water contact angle hysteresis and a much lower value of advancing water contact angle than that of unmodified polyethylene. Interfacial reduction of the plasma modified surfaces by an aqueous solution of sodium borohydride converted surface carbonyl groups into hydroxyl groups which served as active sites for further derivatization and heparin immobilization.;The second approach involved the immobilization of heparin on the biomaterial surfaces. Both cleaved heparin and high affinity heparin were immobilized onto the surfaces of PE, pyrolytic carbon heart valve material and Dacron vascular graft. These materials were modified by hydroxylated plasma polymers followed by coupling with amino-terminated poly(ethylene-oxide) (N-PEO) and 3-amino-propyltriethoxysilane (APTS) before the immobilization of heparin. The anticoagulant activity of heparin immobilized surfaces was determined by a chromogenic assay for the inhibition of factor Xa. Visual confirmation of the presence of HA-heparin on PE was demonstrated by a gold-labeled double antibody method with imaging by SEM and AFM. The presence of heparin on the immobilized surfaces was also confirmed by ESCA analysis.;The third approach involved the physisorption of dextran-containing surfactant on the biomaterial surface. A triblock polymers with hydrophobic hydrocarbon in the middle and hydrophilic dextran molecules in the end has been synthesized. This triblock polymer adsorbed strongly on the biomaterial surfaces in the aqueous condition through the hydrophobic interaction between the hydrophobic surface and the hydrophobic segment in the triblock polymer. The adsorbed triblock polymer exhibited fairly stable and significant protein resistance on PE surfaces.
机译:血液相容性是合成生物材料发展中的主要关注点,因为大多数合成聚合物一旦与血液或组织接触,就会在其表面诱导血栓形成。本文的目的是为现有的生物材料开发表面改性程序,该程序将特异性抑制表面诱导的血栓形成并延长血液接触型生物医学植入物和设备的寿命。已经开发出三种方法来制备生物材料和设备的非血栓形成界面。第一种方法涉及通过射频等离子体放电对生物材料进行表面改性。在PE上沉积了两个等离子聚合物薄膜(约110 nm)。与未改性的聚乙烯相比,等离子体聚合物改性的聚乙烯表面表现出显着的水接触角滞后,并且前进的水接触角值低得多。硼氢化钠水溶液使血浆修饰的表面发生界面还原,将表面羰基转化为羟基,作为进一步衍生化和肝素固定的活性位点。第二种方法涉及将肝素固定在生物材料表面。裂解的肝素和高亲和力的肝素都固定在PE,热解碳心脏瓣膜材料和Dacron血管移植物的表面上。在固定肝素之前,先通过羟基化的等离子聚合物对这些材料进行改性,然后与氨基封端的聚环氧乙烷(N-PEO)和3-氨基丙基三乙氧基硅烷(APTS)偶联。肝素固定化表面的抗凝活性通过发色测定法测定,以抑制因子Xa。用金标记的双抗体方法通过SEM和AFM成像,目测证实PE上存在HA-肝素。通过ESCA分析也证实了固定化表面上肝素的存在。第三种方法涉及在生物材料表面上物理吸附含葡聚糖的表面活性剂。已经合成了在中间具有疏水性烃并且在末端具有亲水性葡聚糖分子的三嵌段聚合物。该三嵌段聚合物在水性条件下通过三嵌段聚合物中疏水表面和疏水链段之间的疏水相互作用而强烈吸附在生物材料表面上。吸附的三嵌段聚合物在PE表面上表现出相当稳定和显着的蛋白质抗性。

著录项

  • 作者

    Yuan, Shengmei.;

  • 作者单位

    Case Western Reserve University.;

  • 授予单位 Case Western Reserve University.;
  • 学科 Chemistry Polymer.;Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 1994
  • 页码 234 p.
  • 总页数 234
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 高分子化学(高聚物);生物医学工程;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号